<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="InterpretationScheuer's Liver Biopsy Interpretation pmcid: 7278535B978-0-7020-7584-1.00006-1 doi: 10.1016/B978-0-7020-7584-1.00006-1 : Article" exact="Acute" post="Viral Hepatitis LefkowitchJay H.MD[], pmc-release: 2020-6-6ppub: 2021epub: 2020-6-689107(C) Elsevier"/>
 <result pre="Liver Biopsy Interpretation pmcid: 7278535B978-0-7020-7584-1.00006-1 doi: 10.1016/B978-0-7020-7584-1.00006-1 : Article Acute" exact="Viral" post="Hepatitis LefkowitchJay H.MD[], pmc-release: 2020-6-6ppub: 2021epub: 2020-6-689107(C) Elsevier Ltd,"/>
 <result pre="Biopsy Interpretation pmcid: 7278535B978-0-7020-7584-1.00006-1 doi: 10.1016/B978-0-7020-7584-1.00006-1 : Article Acute Viral" exact="Hepatitis" post="LefkowitchJay H.MD[], pmc-release: 2020-6-6ppub: 2021epub: 2020-6-689107(C) Elsevier Ltd, 2021Since"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Acute" post="viral hepatitis refers to hepatic infection by the hepatotropic"/>
 <result pre="long as the COVID-19 resource centre remains active. Abstract Acute" exact="viral hepatitis" post="refers to hepatic infection by the hepatotropic viruses hepatitis"/>
 <result pre="as the COVID-19 resource centre remains active. Abstract Acute viral" exact="hepatitis" post="refers to hepatic infection by the hepatotropic viruses hepatitis"/>
 <result pre="centre remains active. Abstract Acute viral hepatitis refers to hepatic" exact="infection" post="by the hepatotropic viruses hepatitis A–E. The acute infections"/>
 <result pre="viral hepatitis refers to hepatic infection by the hepatotropic viruses" exact="hepatitis" post="A–E. The acute infections look similar with regard to"/>
 <result pre="to hepatic infection by the hepatotropic viruses hepatitis A–E. The" exact="acute" post="infections look similar with regard to histologic features, with"/>
 <result pre="hepatic infection by the hepatotropic viruses hepatitis A–E. The acute" exact="infections" post="look similar with regard to histologic features, with spotty"/>
 <result pre="the major differences in the course of each of these" exact="viral" post="infections. Hepatitis A and E are similar in causing"/>
 <result pre="differences in the course of each of these viral infections." exact="Hepatitis" post="A and E are similar in causing only acute"/>
 <result pre="infections. Hepatitis A and E are similar in causing only" exact="acute hepatitis," post="while some cases of hepatitis B and many of"/>
 <result pre="similar in causing only acute hepatitis, while some cases of" exact="hepatitis" post="B and many of hepatitis C become chronic. The"/>
 <result pre="hepatitis, while some cases of hepatitis B and many of" exact="hepatitis" post="C become chronic. The prevalence of hepatitis D virus"/>
 <result pre="and many of hepatitis C become chronic. The prevalence of" exact="hepatitis" post="D virus (HDV) infection has seen a reduction worldwide"/>
 <result pre="C become chronic. The prevalence of hepatitis D virus (HDV)" exact="infection" post="has seen a reduction worldwide due to hepatitis B"/>
 <result pre="virus (HDV) infection has seen a reduction worldwide due to" exact="hepatitis" post="B vaccination programs. Nonetheless, major cities with continued intravenous"/>
 <result pre="rate of approximately 8% in Europe. The availability of direct-acting" exact="viral" post="agents is spearheading efforts by WHO to eliminate new"/>
 <result pre="agents is spearheading efforts by WHO to eliminate new and" exact="chronic" post="HCV infections by 2019. Histologic cholestasis may be a"/>
 <result pre="spearheading efforts by WHO to eliminate new and chronic HCV" exact="infections" post="by 2019. Histologic cholestasis may be a particular feature"/>
 <result pre="to eliminate new and chronic HCV infections by 2019. Histologic" exact="cholestasis" post="may be a particular feature of acute hepatitis E."/>
 <result pre="by 2019. Histologic cholestasis may be a particular feature of" exact="acute hepatitis" post="E. It should be noted that hepatitis E virus"/>
 <result pre="2019. Histologic cholestasis may be a particular feature of acute" exact="hepatitis" post="E. It should be noted that hepatitis E virus"/>
 <result pre="feature of acute hepatitis E. It should be noted that" exact="hepatitis" post="E virus has four major genotypes of which 1"/>
 <result pre="of which 1 and 2 infect humans (resulting in travel/endemic-related" exact="hepatitis" post="with cholestasis and high mortality in pregnant women) and"/>
 <result pre="1 and 2 infect humans (resulting in travel/endemic-related hepatitis with" exact="cholestasis" post="and high mortality in pregnant women) and 3 and"/>
 <result pre="and several other animal and avian species (and may cause" exact="hepatitis" post="associated with poorly or uncooked meat). Keywords Bridging necrosis"/>
 <result pre="with poorly or uncooked meat). Keywords Bridging necrosis Delta virus" exact="Hepatitis" post="A virus Hepatitis B virus Hepatitis C virus Hepatitis"/>
 <result pre="uncooked meat). Keywords Bridging necrosis Delta virus Hepatitis A virus" exact="Hepatitis" post="B virus Hepatitis C virus Hepatitis D virus Hepatitis"/>
 <result pre="Bridging necrosis Delta virus Hepatitis A virus Hepatitis B virus" exact="Hepatitis" post="C virus Hepatitis D virus Hepatitis E virus Spotty"/>
 <result pre="virus Hepatitis A virus Hepatitis B virus Hepatitis C virus" exact="Hepatitis" post="D virus Hepatitis E virus Spotty necrosis Introduction Acute"/>
 <result pre="virus Hepatitis B virus Hepatitis C virus Hepatitis D virus" exact="Hepatitis" post="E virus Spotty necrosis Introduction Acute hepatitis is not"/>
 <result pre="virus Hepatitis D virus Hepatitis E virus Spotty necrosis Introduction" exact="Acute" post="hepatitis is not usually an indication for liver biopsy."/>
 <result pre="Hepatitis D virus Hepatitis E virus Spotty necrosis Introduction Acute" exact="hepatitis" post="is not usually an indication for liver biopsy. There"/>
 <result pre="why pathologists sometimes receive liver biopsy samples from patients with" exact="acute hepatitis." post="First, there may be doubt about the clinical diagnosis,"/>
 <result pre="or even a mistaken working diagnosis. Second, a diagnosis of" exact="hepatitis" post="may be well established but the clinician needs information"/>
 <result pre="but the clinician needs information on the stage of the" exact="disease" post="or its severity. Third, the patient may have received"/>
 <result pre="help decide if symptoms or biochemical abnormalities are due to" exact="recurrent" post="(or new) viral hepatitis or to some other cause"/>
 <result pre="symptoms or biochemical abnormalities are due to recurrent (or new)" exact="viral hepatitis" post="or to some other cause such as rejection. For"/>
 <result pre="or biochemical abnormalities are due to recurrent (or new) viral" exact="hepatitis" post="or to some other cause such as rejection. For"/>
 <result pre="For all these reasons, a knowledge of the pathology of" exact="acute hepatitis" post="is essential. There is a further reason, no less"/>
 <result pre="all these reasons, a knowledge of the pathology of acute" exact="hepatitis" post="is essential. There is a further reason, no less"/>
 <result pre="no less important than the others: without a knowledge of" exact="acute hepatitis," post="the pathologist cannot hope to understand chronic hepatitis and"/>
 <result pre="knowledge of acute hepatitis, the pathologist cannot hope to understand" exact="chronic hepatitis" post="and cirrhosis, together the cause of most liver disease"/>
 <result pre="of acute hepatitis, the pathologist cannot hope to understand chronic" exact="hepatitis" post="and cirrhosis, together the cause of most liver disease"/>
 <result pre="understand chronic hepatitis and cirrhosis, together the cause of most" exact="liver disease" post="in the world. This chapter describes acute viral hepatitis"/>
 <result pre="chronic hepatitis and cirrhosis, together the cause of most liver" exact="disease" post="in the world. This chapter describes acute viral hepatitis"/>
 <result pre="of most liver disease in the world. This chapter describes" exact="acute" post="viral hepatitis and its immediate sequelae in the immunocompetent"/>
 <result pre="most liver disease in the world. This chapter describes acute" exact="viral hepatitis" post="and its immediate sequelae in the immunocompetent patient. The"/>
 <result pre="liver disease in the world. This chapter describes acute viral" exact="hepatitis" post="and its immediate sequelae in the immunocompetent patient. The"/>
 <result pre="sequelae in the immunocompetent patient. The specific problems of diagnosing" exact="hepatitis" post="in an immunosuppressed patient after transplantation are reviewed in"/>
 <result pre="immunosuppressed patient after transplantation are reviewed in Chapter 16. The" exact="hepatitis" post="viruses are listed in Table 6.1 . While several"/>
 <result pre="has so far been established as a definite cause of" exact="viral hepatitis," post="and most episodes of acute and chronic hepatitis can"/>
 <result pre="a definite cause of viral hepatitis, and most episodes of" exact="acute" post="and chronic hepatitis can be attributed to one of"/>
 <result pre="cause of viral hepatitis, and most episodes of acute and" exact="chronic hepatitis" post="can be attributed to one of the viruses listed,"/>
 <result pre="of viral hepatitis, and most episodes of acute and chronic" exact="hepatitis" post="can be attributed to one of the viruses listed,"/>
 <result pre="can be attributed to one of the viruses listed, to" exact="autoimmune" post="hepatitis (Ch. 9) or to a hepatotoxic agent (Ch."/>
 <result pre="be attributed to one of the viruses listed, to autoimmune" exact="hepatitis" post="(Ch. 9) or to a hepatotoxic agent (Ch. 8)."/>
 <result pre="3. including children.4 Occasionally, a virus more often associated with" exact="infection" post="of other organs, such as one of the herpesviruses5.,"/>
 <result pre="hepatitis. These agents are further discussed in Chapter 15. Mild" exact="acute hepatitis" post="has been reported in patients infected with the SARS"/>
 <result pre="These agents are further discussed in Chapter 15. Mild acute" exact="hepatitis" post="has been reported in patients infected with the SARS"/>
 <result pre="been reported in patients infected with the SARS virus (severe" exact="acute" post="respiratory syndrome-associated coronavirus).10., 11.Table 6.1 The hepatitis viruses Virus"/>
 <result pre="reported in patients infected with the SARS virus (severe acute" exact="respiratory" post="syndrome-associated coronavirus).10., 11.Table 6.1 The hepatitis viruses Virus Type"/>
 <result pre="SARS virus (severe acute respiratory syndrome-associated coronavirus).10., 11.Table 6.1 The" exact="hepatitis" post="viruses Virus Type Spread and disease Hepatitis A (HAV)"/>
 <result pre="coronavirus).10., 11.Table 6.1 The hepatitis viruses Virus Type Spread and" exact="disease" post="Hepatitis A (HAV) RNA hepatovirus Faecal–oral, acute Hepatitis B"/>
 <result pre="11.Table 6.1 The hepatitis viruses Virus Type Spread and disease" exact="Hepatitis" post="A (HAV) RNA hepatovirus Faecal–oral, acute Hepatitis B (HBV)"/>
 <result pre="Type Spread and disease Hepatitis A (HAV) RNA hepatovirus Faecal–oral," exact="acute" post="Hepatitis B (HBV) DNA hepadnavirus Parenteral, acute or chronic"/>
 <result pre="Spread and disease Hepatitis A (HAV) RNA hepatovirus Faecal–oral, acute" exact="Hepatitis" post="B (HBV) DNA hepadnavirus Parenteral, acute or chronic Hepatitis"/>
 <result pre="RNA hepatovirus Faecal–oral, acute Hepatitis B (HBV) DNA hepadnavirus Parenteral," exact="acute" post="or chronic Hepatitis C (HCV) RNA hepacivirus Parenteral or"/>
 <result pre="hepatovirus Faecal–oral, acute Hepatitis B (HBV) DNA hepadnavirus Parenteral, acute" exact="or chronic" post="Hepatitis C (HCV) RNA hepacivirus Parenteral or sporadic; acute,"/>
 <result pre="Faecal–oral, acute Hepatitis B (HBV) DNA hepadnavirus Parenteral, acute or" exact="chronic" post="Hepatitis C (HCV) RNA hepacivirus Parenteral or sporadic; acute,"/>
 <result pre="acute Hepatitis B (HBV) DNA hepadnavirus Parenteral, acute or chronic" exact="Hepatitis" post="C (HCV) RNA hepacivirus Parenteral or sporadic; acute, more"/>
 <result pre="C (HCV) RNA hepacivirus Parenteral or sporadic; acute, more often" exact="chronic" post="Hepatitis D (HDV) RNA deltavirus, defective Pathogenic when combined"/>
 <result pre="(HCV) RNA hepacivirus Parenteral or sporadic; acute, more often chronic" exact="Hepatitis" post="D (HDV) RNA deltavirus, defective Pathogenic when combined with"/>
 <result pre="D (HDV) RNA deltavirus, defective Pathogenic when combined with HBV" exact="Hepatitis" post="E (HEV) RNA virus Faecal–oral, epidemic or sporadic acute"/>
 <result pre="HBV Hepatitis E (HEV) RNA virus Faecal–oral, epidemic or sporadic" exact="acute" post="disease Occasionally, mild serum liver test abnormalities and mild"/>
 <result pre="Hepatitis E (HEV) RNA virus Faecal–oral, epidemic or sporadic acute" exact="disease" post="Occasionally, mild serum liver test abnormalities and mild histological"/>
 <result pre="disease Occasionally, mild serum liver test abnormalities and mild histological" exact="hepatitis" post="(bystander hepatitis) with apoptotic bodies, focal necrosis and lymphocytic"/>
 <result pre="abnormalities and mild histological hepatitis (bystander hepatitis) with apoptotic bodies," exact="focal" post="necrosis and lymphocytic inflammation are seen in systemic, non-hepatic"/>
 <result pre="focal necrosis and lymphocytic inflammation are seen in systemic, non-hepatic" exact="viral" post="infections such as pulmonary influenza and result from migration"/>
 <result pre="necrosis and lymphocytic inflammation are seen in systemic, non-hepatic viral" exact="infections" post="such as pulmonary influenza and result from migration to"/>
 <result pre="inflammation are seen in systemic, non-hepatic viral infections such as" exact="pulmonary" post="influenza and result from migration to the liver of,"/>
 <result pre="T lymphocytes.12., 13. Pathological features The essential components of the" exact="acute" post="phase of hepatitis are inflammatory-cell infiltration and hepatocellular damage."/>
 <result pre="Pathological features The essential components of the acute phase of" exact="hepatitis" post="are inflammatory-cell infiltration and hepatocellular damage. Other features include"/>
 <result pre="activation, endotheliitis, bile-duct damage, the ductular reaction and hepatocellular regeneration." exact="Hepatocellular" post="damage Changes seen under the light microscope range from"/>
 <result pre="A periportal pattern of necrosis and inflammation, sometimes seen in" exact="hepatitis" post="A, is less common. Fig. 6.1 Acute viral hepatitis."/>
 <result pre="sometimes seen in hepatitis A, is less common. Fig. 6.1" exact="Acute" post="viral hepatitis. Surviving hepatocytes in the perivenular area in"/>
 <result pre="seen in hepatitis A, is less common. Fig. 6.1 Acute" exact="viral hepatitis." post="Surviving hepatocytes in the perivenular area in the centre"/>
 <result pre="plane of the section. Another form of hepatocellular damage in" exact="acute hepatitis" post="is focal (spotty) necrosis, in which liver-cell plates are"/>
 <result pre="of the section. Another form of hepatocellular damage in acute" exact="hepatitis" post="is focal (spotty) necrosis, in which liver-cell plates are"/>
 <result pre="section. Another form of hepatocellular damage in acute hepatitis is" exact="focal" post="(spotty) necrosis, in which liver-cell plates are disrupted or"/>
 <result pre="its mechanism, loss of hepatocytes or liver-cell drop-out, coupled with" exact="focal" post="regeneration, leads to a characteristic irregularity of the liver-cell"/>
 <result pre="a characteristic irregularity of the liver-cell plates, which usually allows" exact="acute hepatitis" post="to be distinguished from hepatocellular damage secondary to cholestasis."/>
 <result pre="characteristic irregularity of the liver-cell plates, which usually allows acute" exact="hepatitis" post="to be distinguished from hepatocellular damage secondary to cholestasis."/>
 <result pre="usually allows acute hepatitis to be distinguished from hepatocellular damage" exact="secondary" post="to cholestasis. The loss of hepatocytes also leads to"/>
 <result pre="best seen in reticulin preparations (Fig. 6.4 ). Fig. 6.2" exact="Acute" post="viral hepatitis. Normal liver-cell plate structure is disrupted. Hepatocytes"/>
 <result pre="seen in reticulin preparations (Fig. 6.4 ). Fig. 6.2 Acute" exact="viral hepatitis." post="Normal liver-cell plate structure is disrupted. Hepatocytes vary in"/>
 <result pre="reticulin preparations (Fig. 6.4 ). Fig. 6.2 Acute viral hepatitis." exact="Normal" post="liver-cell plate structure is disrupted. Hepatocytes vary in size,"/>
 <result pre="An apoptotic hepatocyte is seen left of centre. Fig. 6.3" exact="Acute" post="yellow-fever hepatitis. There is prominent mid-zonal necrosis (between arrows)"/>
 <result pre="many apoptotic hepatocytes and scattered lymphocytes. The portal tract at" exact="lower" post="right is mildly inflamed and there is relative preservation"/>
 <result pre="Inset: The numerous apoptotic (Councilman) bodies present (arrows) are characteristic" exact="of liver" post="involvement in yellow fever. Fig. 6.4 Acute viral hepatitis."/>
 <result pre="(Councilman) bodies present (arrows) are characteristic of liver involvement in" exact="yellow fever." post="Fig. 6.4 Acute viral hepatitis. The reticulin framework is"/>
 <result pre="are characteristic of liver involvement in yellow fever. Fig. 6.4" exact="Acute" post="viral hepatitis. The reticulin framework is condensed near the"/>
 <result pre="characteristic of liver involvement in yellow fever. Fig. 6.4 Acute" exact="viral hepatitis." post="The reticulin framework is condensed near the efferent venules"/>
 <result pre="When syncytial giant hepatocytes are very prominent, the term giant-cell" exact="hepatitis" post="is appropriate.17., 18. This is only rarely of proven"/>
 <result pre="hepatitis is appropriate.17., 18. This is only rarely of proven" exact="viral" post="origin and is also more characteristic of acute hepatitis"/>
 <result pre="of proven viral origin and is also more characteristic of" exact="acute hepatitis" post="in neonates. In adults, autoimmune hepatitis and hepatitis C"/>
 <result pre="proven viral origin and is also more characteristic of acute" exact="hepatitis" post="in neonates. In adults, autoimmune hepatitis and hepatitis C"/>
 <result pre="also more characteristic of acute hepatitis in neonates. In adults," exact="autoimmune" post="hepatitis and hepatitis C virus with or without human"/>
 <result pre="more characteristic of acute hepatitis in neonates. In adults, autoimmune" exact="hepatitis" post="and hepatitis C virus with or without human immunodeficiency"/>
 <result pre="of acute hepatitis in neonates. In adults, autoimmune hepatitis and" exact="hepatitis" post="C virus with or without human immunodeficiency virus co-infection"/>
 <result pre="autoimmune hepatitis and hepatitis C virus with or without human" exact="immunodeficiency" post="virus co-infection are important associations.19., 20., 21., 22., 23."/>
 <result pre="immunodeficiency virus co-infection are important associations.19., 20., 21., 22., 23." exact="Cholestasis" post="in the form of bile thrombi in canaliculi is"/>
 <result pre="the form of bile thrombi in canaliculi is common in" exact="acute hepatitis" post="but rare in chronic hepatitis, which is diagnostically helpful."/>
 <result pre="form of bile thrombi in canaliculi is common in acute" exact="hepatitis" post="but rare in chronic hepatitis, which is diagnostically helpful."/>
 <result pre="in canaliculi is common in acute hepatitis but rare in" exact="chronic hepatitis," post="which is diagnostically helpful. It is a result of"/>
 <result pre="at the level of the portal tracts.24 The term cholestatic" exact="hepatitis" post="is best kept as a clinical description of patients"/>
 <result pre="description of patients with a prolonged cholestatic course. Mild hepatocellular" exact="siderosis" post="or steatosis is occasionally seen. The inflammatory infiltrate Unlike"/>
 <result pre="or steatosis is occasionally seen. The inflammatory infiltrate Unlike classic" exact="acute" post="inflammation, viral hepatitis is characterised by a mainly lymphocytic"/>
 <result pre="is occasionally seen. The inflammatory infiltrate Unlike classic acute inflammation," exact="viral hepatitis" post="is characterised by a mainly lymphocytic infiltrate within the"/>
 <result pre="occasionally seen. The inflammatory infiltrate Unlike classic acute inflammation, viral" exact="hepatitis" post="is characterised by a mainly lymphocytic infiltrate within the"/>
 <result pre="mainly lymphocytic infiltrate within the parenchyma and portal tracts. In" exact="acute hepatitis," post="the most conspicuous inflammation is usually perivenular. The extent"/>
 <result pre="extension of the infiltrate. This so-called spillover resembles the interface" exact="hepatitis" post="of chronic hepatitis (Ch. 9) and may be difficult"/>
 <result pre="the infiltrate. This so-called spillover resembles the interface hepatitis of" exact="chronic hepatitis" post="(Ch. 9) and may be difficult to distinguish from"/>
 <result pre="infiltrate. This so-called spillover resembles the interface hepatitis of chronic" exact="hepatitis" post="(Ch. 9) and may be difficult to distinguish from"/>
 <result pre="usually make the correct diagnosis clear. While most of the" exact="infiltrating" post="cells in acute hepatitis are small T lymphocytes,25 plasma"/>
 <result pre="correct diagnosis clear. While most of the infiltrating cells in" exact="acute hepatitis" post="are small T lymphocytes,25 plasma cells may also be"/>
 <result pre="diagnosis clear. While most of the infiltrating cells in acute" exact="hepatitis" post="are small T lymphocytes,25 plasma cells may also be"/>
 <result pre="neutrophils and eosinophils. The plasma cells do not necessarily indicate" exact="autoimmune" post="hepatitis, nor do a few eosinophils prove a diagnosis"/>
 <result pre="with lymphocytes. They may contain tan-brown ceroid pigment, staining with" exact="periodic" post="acid–Schiff (PAS) agent after diastase digestion (Fig. 6.5 )."/>
 <result pre="(Fig. 6.6 ), but this is less common. Fig. 6.5" exact="Acute" post="viral hepatitis. Macrophages contain diastase periodic acid–Schiff (PAS)-positive material."/>
 <result pre="6.6 ), but this is less common. Fig. 6.5 Acute" exact="viral hepatitis." post="Macrophages contain diastase periodic acid–Schiff (PAS)-positive material. Fig. 6.6"/>
 <result pre="less common. Fig. 6.5 Acute viral hepatitis. Macrophages contain diastase" exact="periodic" post="acid–Schiff (PAS)-positive material. Fig. 6.6 Acute viral hepatitis. Enlarged"/>
 <result pre="hepatitis. Macrophages contain diastase periodic acid–Schiff (PAS)-positive material. Fig. 6.6" exact="Acute" post="viral hepatitis. Enlarged macrophages are strongly iron positive. Some"/>
 <result pre="Macrophages contain diastase periodic acid–Schiff (PAS)-positive material. Fig. 6.6 Acute" exact="viral hepatitis." post="Enlarged macrophages are strongly iron positive. Some endothelial cells"/>
 <result pre="the endothelium and lymphocytic infiltration. Portal changes In contrast to" exact="chronic hepatitis," post="the parenchymal changes dominate the picture, but there is"/>
 <result pre="lymphoid structures (aggregates and follicles), are most often seen in" exact="hepatitis" post="C. Bile-duct loss (ductopenia) is very rare. Fig. 6.7"/>
 <result pre="hepatitis C. Bile-duct loss (ductopenia) is very rare. Fig. 6.7" exact="Acute" post="viral hepatitis. A portal tract is infiltrated by inflammatory"/>
 <result pre="C. Bile-duct loss (ductopenia) is very rare. Fig. 6.7 Acute" exact="viral hepatitis." post="A portal tract is infiltrated by inflammatory cells, mainly"/>
 <result pre="inflammatory cells, mainly lymphocytes. In places the infiltrate extends a" exact="short" post="way into the adjacent parenchyma. Fig. 6.8 Acute viral"/>
 <result pre="extends a short way into the adjacent parenchyma. Fig. 6.8" exact="Acute" post="viral hepatitis. Bile-duct epithelium is irregular and infiltrated by"/>
 <result pre="a short way into the adjacent parenchyma. Fig. 6.8 Acute" exact="viral hepatitis." post="Bile-duct epithelium is irregular and infiltrated by lymphocytes. The"/>
 <result pre="hepatitis. Bile-duct epithelium is irregular and infiltrated by lymphocytes. The" exact="upper" post="duct profile shows epithelial atrophy and dilatation. Histological variants"/>
 <result pre="irregular and infiltrated by lymphocytes. The upper duct profile shows" exact="epithelial" post="atrophy and dilatation. Histological variants The histological changes in"/>
 <result pre="and infiltrated by lymphocytes. The upper duct profile shows epithelial" exact="atrophy" post="and dilatation. Histological variants The histological changes in acute"/>
 <result pre="epithelial atrophy and dilatation. Histological variants The histological changes in" exact="acute hepatitis" post="are infinitely variable, but a few patterns deserve special"/>
 <result pre="atrophy and dilatation. Histological variants The histological changes in acute" exact="hepatitis" post="are infinitely variable, but a few patterns deserve special"/>
 <result pre="zonal areas of confluent necrosis haphazardly distributed in relation to" exact="lobular" post="zones are more likely to be due to causes"/>
 <result pre="are more likely to be due to causes other than" exact="acute" post="viral hepatitis; possibilities to be considered include opportunistic infections"/>
 <result pre="more likely to be due to causes other than acute" exact="viral hepatitis;" post="possibilities to be considered include opportunistic infections with herpes"/>
 <result pre="than acute viral hepatitis; possibilities to be considered include opportunistic" exact="infections" post="with herpes simplex or zoster viruses and lymphoma. Bridging"/>
 <result pre="viral hepatitis; possibilities to be considered include opportunistic infections with" exact="herpes" post="simplex or zoster viruses and lymphoma. Bridging necrosis (Fig."/>
 <result pre="to be considered include opportunistic infections with herpes simplex or" exact="zoster" post="viruses and lymphoma. Bridging necrosis (Fig. 6.10, Fig. 6.9,"/>
 <result pre="of many bridges. Bridging necrosis is a manifestation of severe" exact="acute hepatitis," post="but its distribution even within a single biopsy may"/>
 <result pre="of portal tracts, with or without periportal necrosis. Fig. 6.10" exact="Acute" post="viral hepatitis: bridging necrosis. Recent collapse following confluent necrosis"/>
 <result pre="portal tracts, with or without periportal necrosis. Fig. 6.10 Acute" exact="viral" post="hepatitis: bridging necrosis. Recent collapse following confluent necrosis is"/>
 <result pre="periportal necrosis. Fig. 6.10 Acute viral hepatitis: bridging necrosis. Recent" exact="collapse" post="following confluent necrosis is seen as condensation of reticulin,"/>
 <result pre="is seen as condensation of reticulin, mimicking fibrosis. Fig. 6.9" exact="Acute" post="viral hepatitis: bridging necrosis. Two curved lines of collapse"/>
 <result pre="seen as condensation of reticulin, mimicking fibrosis. Fig. 6.9 Acute" exact="viral" post="hepatitis: bridging necrosis. Two curved lines of collapse (arrows)"/>
 <result pre="6.9 Acute viral hepatitis: bridging necrosis. Two curved lines of" exact="collapse" post="(arrows) extend from a portal tract (P). An efferent"/>
 <result pre="is seen top centre. Bridges of confluent necrosis with subsequent" exact="collapse" post="may be mistaken for the septa of chronic liver"/>
 <result pre="with subsequent collapse may be mistaken for the septa of" exact="chronic" post="liver disease. In making the important distinction between them,"/>
 <result pre="subsequent collapse may be mistaken for the septa of chronic" exact="liver disease." post="In making the important distinction between them, the pathologist"/>
 <result pre="the parenchyma, but elastic tissue accumulates as septa age.28 Recent" exact="collapse" post="is therefore negative (Fig. 6.11 ), whereas old septa"/>
 <result pre="1 or 2 months after onset of hepatitis.29 Fig. 6.11" exact="Acute" post="hepatitis: bridging necrosis. The field is the same as"/>
 <result pre="negative. Inset: This contrasts with an elastic fibre-rich septum in" exact="chronic" post="liver disease. In a minority of patients with acute"/>
 <result pre="Inset: This contrasts with an elastic fibre-rich septum in chronic" exact="liver disease." post="In a minority of patients with acute viral hepatitis,"/>
 <result pre="in chronic liver disease. In a minority of patients with" exact="acute" post="viral hepatitis, confluent necrosis extends throughout entire lobules or"/>
 <result pre="chronic liver disease. In a minority of patients with acute" exact="viral hepatitis," post="confluent necrosis extends throughout entire lobules or acini (panlobular"/>
 <result pre="can lead to over- or underestimation of the true extent" exact="of liver" post="damage.30 This throws doubt on the usefulness of liver"/>
 <result pre="extent of liver damage.30 This throws doubt on the usefulness" exact="of liver" post="biopsy as a means of assessing prognosis in severe"/>
 <result pre="liver biopsy as a means of assessing prognosis in severe" exact="acute hepatitis." post="Sometimes multilobular necrosis involves only the subcapsular zone, and"/>
 <result pre="‘Late-onset hepatic failure’ is a term used for patients developing" exact="encephalopathy" post="between 8 and 24 weeks after onset of symptoms.34"/>
 <result pre="between 8 and 24 weeks after onset of symptoms.34 Study" exact="of liver" post="biopsies and explanted livers from these patients has shown"/>
 <result pre="a consistent pattern of map-like necrosis together with areas of" exact="nodular" post="regeneration. Fig. 6.12 Acute viral hepatitis: multilobular necrosis. Portal"/>
 <result pre="map-like necrosis together with areas of nodular regeneration. Fig. 6.12" exact="Acute" post="viral hepatitis: multilobular necrosis. Portal tracts (P) can be"/>
 <result pre="necrosis together with areas of nodular regeneration. Fig. 6.12 Acute" exact="viral" post="hepatitis: multilobular necrosis. Portal tracts (P) can be identified,"/>
 <result pre="usual perivenular necrosis is a feature in some patients with" exact="hepatitis" post="A (discussed later). Individual causes of viral hepatitis There"/>
 <result pre="some patients with hepatitis A (discussed later). Individual causes of" exact="viral hepatitis" post="There are more similarities than differences between hepatitis types"/>
 <result pre="patients with hepatitis A (discussed later). Individual causes of viral" exact="hepatitis" post="There are more similarities than differences between hepatitis types"/>
 <result pre="of viral hepatitis There are more similarities than differences between" exact="hepatitis" post="types A, B, C, D and E, but certain"/>
 <result pre="not allow the pathologist to identify the cause of the" exact="hepatitis" post="on histological appearance alone. The picture may be confused"/>
 <result pre="more than one virus, or by additional damage resulting from" exact="alcohol abuse." post="Hepatitis A Two main patterns are described, occurring separately"/>
 <result pre="one virus, or by additional damage resulting from alcohol abuse." exact="Hepatitis" post="A Two main patterns are described, occurring separately or"/>
 <result pre="together.35., 36., 37. One is a histological picture of perivenular" exact="cholestasis" post="with little liver-cell damage or inflammation, easily mistaken for"/>
 <result pre="liver-cell damage or inflammation, easily mistaken for other causes of" exact="cholestasis" post="(Fig. 6.13 ). The second is a hepatitis with"/>
 <result pre="causes of cholestasis (Fig. 6.13 ). The second is a" exact="hepatitis" post="with periportal necrosis and a dense portal infiltrate which"/>
 <result pre="(Fig. 6.14 ). These two patterns may be related, the" exact="cholestasis" post="resulting from interruption of bile flow by the periportal"/>
 <result pre="of bile flow by the periportal necrosis.23 Other patterns of" exact="hepatitis" post="as described earlier are also found, but fulminant hepatitis"/>
 <result pre="of hepatitis as described earlier are also found, but fulminant" exact="hepatitis" post="with multilobular necrosis is rare. Extensive microvesicular change of"/>
 <result pre="is rare. Extensive microvesicular change of hepatocytes, previously described in" exact="hepatitis" post="D infection, has been seen also in severe acute"/>
 <result pre="in hepatitis D infection, has been seen also in severe" exact="acute hepatitis" post="A (Fig. 6.15 ). Fibrin-ring granulomas have been reported.38.,"/>
 <result pre="hepatitis D infection, has been seen also in severe acute" exact="hepatitis" post="A (Fig. 6.15 ). Fibrin-ring granulomas have been reported.38.,"/>
 <result pre="(Fig. 6.15 ). Fibrin-ring granulomas have been reported.38., 39. A" exact="chronic" post="course40 is very rare. Fig. 6.13 Hepatitis A. Perivenular"/>
 <result pre="reported.38., 39. A chronic course40 is very rare. Fig. 6.13" exact="Hepatitis" post="A. Perivenular area showing irregularity of liver-cell plates and"/>
 <result pre="Hepatitis A. Perivenular area showing irregularity of liver-cell plates and" exact="cholestasis" post="but only mild inflammatory infiltration. Fig. 6.14 Hepatitis A."/>
 <result pre="plates and cholestasis but only mild inflammatory infiltration. Fig. 6.14" exact="Hepatitis" post="A. The portal area at right is heavily infiltrated"/>
 <result pre="The limiting plate is irregular. The picture resembles that of" exact="chronic hepatitis" post="with interface hepatitis. Fig. 6.15 Hepatitis A. In this"/>
 <result pre="limiting plate is irregular. The picture resembles that of chronic" exact="hepatitis" post="with interface hepatitis. Fig. 6.15 Hepatitis A. In this"/>
 <result pre="resembles that of chronic hepatitis with interface hepatitis. Fig. 6.15" exact="Hepatitis" post="A. In this patient with a clinical picture of"/>
 <result pre="of fulminant hepatitis, hepatocytes are swollen and microvesicular. There is" exact="cholestasis" post="and a lymphocytic infiltrate. Hepatitis B The histological appearances"/>
 <result pre="swollen and microvesicular. There is cholestasis and a lymphocytic infiltrate." exact="Hepatitis" post="B The histological appearances are broadly similar to those"/>
 <result pre="appearances are broadly similar to those of other forms of" exact="viral hepatitis." post="Some of the differences reported in the literature may"/>
 <result pre="may well reflect patient selection rather than features specific for" exact="hepatitis" post="B virus (HBV) infection. However, lymphocytes and macrophages sometimes"/>
 <result pre="comparative study, periportal inflammation tended to be more severe in" exact="acute hepatitis" post="B than in hepatitis C.41 Liver cells and their"/>
 <result pre="study, periportal inflammation tended to be more severe in acute" exact="hepatitis" post="B than in hepatitis C.41 Liver cells and their"/>
 <result pre="to be more severe in acute hepatitis B than in" exact="hepatitis" post="C.41 Liver cells and their nuclei may show a"/>
 <result pre="show a moderate degree of pleomorphism. In most cases of" exact="acute hepatitis," post="the hepatitis B core and surface antigens (HBcAg and"/>
 <result pre="degree of pleomorphism. In most cases of acute hepatitis, the" exact="hepatitis" post="B core and surface antigens (HBcAg and HBsAg) are"/>
 <result pre="staining of surface material with Victoria blue or orcein indicates" exact="chronic" post="disease. Recurrence of HBV infection after liver transplantation is"/>
 <result pre="Victoria blue or orcein indicates chronic disease. Recurrence of HBV" exact="infection" post="after liver transplantation is an exception to this rule,"/>
 <result pre="a result of intravenous drug abuse.42 Following clinical recovery of" exact="acute hepatitis" post="B, occult infection and mild histological abnormalities including portal"/>
 <result pre="result of intravenous drug abuse.42 Following clinical recovery of acute" exact="hepatitis" post="B, occult infection and mild histological abnormalities including portal"/>
 <result pre="drug abuse.42 Following clinical recovery of acute hepatitis B, occult" exact="infection" post="and mild histological abnormalities including portal inflammation, focal necrosis,"/>
 <result pre="B, occult infection and mild histological abnormalities including portal inflammation," exact="focal" post="necrosis, apoptosis and fibrosis may persist for at least"/>
 <result pre="least a decade.43 Reactivation of a previously occult or quiescent" exact="chronic hepatitis" post="B infection may cause changes closely resembling acute hepatitis."/>
 <result pre="a decade.43 Reactivation of a previously occult or quiescent chronic" exact="hepatitis" post="B infection may cause changes closely resembling acute hepatitis."/>
 <result pre="Reactivation of a previously occult or quiescent chronic hepatitis B" exact="infection" post="may cause changes closely resembling acute hepatitis. In such"/>
 <result pre="quiescent chronic hepatitis B infection may cause changes closely resembling" exact="acute hepatitis." post="In such instances the presence of (1) portal tract"/>
 <result pre="on immunostaining points to the underlying chronicity of the process." exact="Hepatitis" post="C Usually the histological features of hepatitis C are"/>
 <result pre="of the process. Hepatitis C Usually the histological features of" exact="hepatitis" post="C are those of any acute hepatitis, but two"/>
 <result pre="the histological features of hepatitis C are those of any" exact="acute hepatitis," post="but two distinguishing features have been noted. First, there"/>
 <result pre="may be prominent infiltration of sinusoids by lymphocytes in the" exact="absence of" post="severe liver-cell damage,44 giving rise to a picture reminiscent"/>
 <result pre="severe liver-cell damage,44 giving rise to a picture reminiscent of" exact="infectious mononucleosis" post="(Fig. 6.16 ). Second, lymphoid follicles and bile-duct damage,"/>
 <result pre="liver-cell damage,44 giving rise to a picture reminiscent of infectious" exact="mononucleosis" post="(Fig. 6.16 ). Second, lymphoid follicles and bile-duct damage,"/>
 <result pre="Second, lymphoid follicles and bile-duct damage, features also associated with" exact="chronic hepatitis," post="may be seen within a few weeks or months"/>
 <result pre="There may be cholestasis. The common finding of steatosis in" exact="hepatitis" post="C is discussed in Chapter 9. Fulminant hepatitis C"/>
 <result pre="steatosis in hepatitis C is discussed in Chapter 9. Fulminant" exact="hepatitis" post="C is very rare in the Western world,3 but"/>
 <result pre="but may be commoner in parts of Asia.46 Fig. 6.16" exact="Acute" post="hepatitis C. In this example the main abnormality is"/>
 <result pre="may be commoner in parts of Asia.46 Fig. 6.16 Acute" exact="hepatitis" post="C. In this example the main abnormality is infiltration"/>
 <result pre="example the main abnormality is infiltration of sinusoids by lymphocytes." exact="Hepatitis" post="D (delta hepatitis) Co-infection or superinfection with the hepatitis"/>
 <result pre="lymphocytes. Hepatitis D (delta hepatitis) Co-infection or superinfection with the" exact="hepatitis" post="D virus (HDV) alters the course of type B"/>
 <result pre="with the hepatitis D virus (HDV) alters the course of" exact="type B" post="hepatitis. It encourages chronicity and enhances severity,47., 48., 49."/>
 <result pre="hepatocyte nuclei (Fig. 6.17 ). These may have finely granular" exact="eosinophilic" post="centres (so-called sanded nuclei50). Cytoplasmic and membrane-associated staining is"/>
 <result pre="and membrane-associated staining is also sometimes seen. Fig. 6.17 Delta" exact="hepatitis" post="(HDV). Some hepatocyte nuclei contain the delta antigen and"/>
 <result pre="and are stained red. There is a substantial lymphocytic infiltrate." exact="Severe" post="acute hepatitis in a patient with markers of HBV"/>
 <result pre="are stained red. There is a substantial lymphocytic infiltrate. Severe" exact="acute hepatitis" post="in a patient with markers of HBV infection may"/>
 <result pre="stained red. There is a substantial lymphocytic infiltrate. Severe acute" exact="hepatitis" post="in a patient with markers of HBV infection may"/>
 <result pre="Severe acute hepatitis in a patient with markers of HBV" exact="infection" post="may be due to superinfection by HDV of a"/>
 <result pre="infection may be due to superinfection by HDV of a" exact="chronic" post="HBV carrier.51 In an outbreak of HDV infection among"/>
 <result pre="of a chronic HBV carrier.51 In an outbreak of HDV" exact="infection" post="among Venezuelan Indians, notable features included early small-droplet fatty"/>
 <result pre="by contrast, HDV without HBV is sometimes demonstrable in the" exact="absence of" post="hepatitic changes, indicating that HDV can survive in the"/>
 <result pre="of hepatitic changes, indicating that HDV can survive in the" exact="absence of" post="HBV. It does not then appear, however, to be"/>
 <result pre="then appear, however, to be capable of causing liver damage.56" exact="Hepatitis" post="E virus LBI-10 Hepatitis E virus (HEV) is an"/>
 <result pre="be capable of causing liver damage.56 Hepatitis E virus LBI-10" exact="Hepatitis" post="E virus (HEV) is an RNA virus with eight"/>
 <result pre="foxes, dromedary camels and horses and cause zoonotic, autochthonous (i.e.," exact="acquired" post="regionally) infections, typically through poorly or undercooked meat.58b., 58c."/>
 <result pre="been found in Africa, North and South America and Europe." exact="Infections" post="with genotypes 1 and 2 resulted in an estimated"/>
 <result pre="genotypes 1 and 2 resulted in an estimated &amp;gt;3 million" exact="symptomatic" post="cases and 70,000 fatalities in endemic regions in 2005.59a.,"/>
 <result pre="among which genotype 3 is the most common, have caused" exact="acute hepatitis" post="in North America and Europe57., 60. but sometimes is"/>
 <result pre="which genotype 3 is the most common, have caused acute" exact="hepatitis" post="in North America and Europe57., 60. but sometimes is"/>
 <result pre="but sometimes is misdiagnosed as drug-induced liver injury.61a., 61b., 61c." exact="Chronic" post="hepatitis E has been described in organ transplant recipients"/>
 <result pre="sometimes is misdiagnosed as drug-induced liver injury.61a., 61b., 61c. Chronic" exact="hepatitis" post="E has been described in organ transplant recipients and"/>
 <result pre="immunosuppressed individuals.62., 63a., 63b. Information about the pathology of HEV" exact="infection" post="in humans is emerging,58a., 61a., 63c. although many of"/>
 <result pre="features are similar to those seen in other types of" exact="viral hepatitis" post="or in autoimmune or drug-induced hepatitis.58a., 61a. The morphology"/>
 <result pre="are similar to those seen in other types of viral" exact="hepatitis" post="or in autoimmune or drug-induced hepatitis.58a., 61a. The morphology"/>
 <result pre="those seen in other types of viral hepatitis or in" exact="autoimmune" post="or drug-induced hepatitis.58a., 61a. The morphology depends on the"/>
 <result pre="viral hepatitis or in autoimmune or drug-induced hepatitis.58a., 61a. The" exact="morphology" post="depends on the HEV viral genotype and on the"/>
 <result pre="or drug-induced hepatitis.58a., 61a. The morphology depends on the HEV" exact="viral" post="genotype and on the clinicopathological setting58a., 63a., 64., 65.,"/>
 <result pre="64., 65., 66., 67. (see Box 6.1 ). Foci of" exact="lobular" post="necroinflammation with intrasinusoidal pigmented, ceroid-laden Kupffer cells are prominent"/>
 <result pre="with intrasinusoidal pigmented, ceroid-laden Kupffer cells are prominent in the" exact="acute" post="infection (Fig. 6.18 ).58aEpidemic (genotype 1 or 2) hepatitis"/>
 <result pre="intrasinusoidal pigmented, ceroid-laden Kupffer cells are prominent in the acute" exact="infection" post="(Fig. 6.18 ).58aEpidemic (genotype 1 or 2) hepatitis E"/>
 <result pre="the acute infection (Fig. 6.18 ).58aEpidemic (genotype 1 or 2)" exact="hepatitis" post="E is well known for its potential for severe"/>
 <result pre="hepatitis E is well known for its potential for severe" exact="hepatic disease," post="acute liver failure and massive hepatic necrosis, but some"/>
 <result pre="is well known for its potential for severe hepatic disease," exact="acute" post="liver failure and massive hepatic necrosis, but some cases"/>
 <result pre="well known for its potential for severe hepatic disease, acute" exact="liver failure" post="and massive hepatic necrosis, but some cases have shown"/>
 <result pre="massive hepatic necrosis, but some cases have shown prolonged clinical" exact="cholestasis" post="with bile canalicular cholestasis and cholestatic rosettes on biopsy."/>
 <result pre="some cases have shown prolonged clinical cholestasis with bile canalicular" exact="cholestasis" post="and cholestatic rosettes on biopsy. The changes may resemble"/>
 <result pre="cholestatic rosettes on biopsy. The changes may resemble those of" exact="hepatitis" post="A, with prominent cholestasis and a predominantly portal and"/>
 <result pre="The changes may resemble those of hepatitis A, with prominent" exact="cholestasis" post="and a predominantly portal and periportal inflammatory infiltrate.68 In"/>
 <result pre="infiltrate.68 In one study, a pregnant woman with fatal epidemic" exact="hepatitis" post="E the liver showed little portal inflammation, much cholestasis"/>
 <result pre="epidemic hepatitis E the liver showed little portal inflammation, much" exact="cholestasis" post="with prominent portal vein and central vein endotheliitis and"/>
 <result pre="cholestasis with prominent portal vein and central vein endotheliitis and" exact="viral" post="particles were identified in bile ductules by electron microscopy.69Cases"/>
 <result pre="were identified in bile ductules by electron microscopy.69Cases of autochthonous" exact="hepatitis" post="E (usually genotype 3) have shown portal lymphoid aggregates"/>
 <result pre="In immunocompromised subjects with organ transplants, immundeficiencies or corticosteroid therapy," exact="chronic hepatitis" post="E manifests with the classical features of chronic hepatitis"/>
 <result pre="immunocompromised subjects with organ transplants, immundeficiencies or corticosteroid therapy, chronic" exact="hepatitis" post="E manifests with the classical features of chronic hepatitis"/>
 <result pre="therapy, chronic hepatitis E manifests with the classical features of" exact="chronic hepatitis" post="(i.e., interface hepatitis with variable lobular necroinflammation), but portal"/>
 <result pre="chronic hepatitis E manifests with the classical features of chronic" exact="hepatitis" post="(i.e., interface hepatitis with variable lobular necroinflammation), but portal"/>
 <result pre="manifests with the classical features of chronic hepatitis (i.e., interface" exact="hepatitis" post="with variable lobular necroinflammation), but portal tract neutrophilia with"/>
 <result pre="classical features of chronic hepatitis (i.e., interface hepatitis with variable" exact="lobular" post="necroinflammation), but portal tract neutrophilia with bile duct damage,"/>
 <result pre="destruction, may be prominent.70Box 6.1 Major clinicopathological settings of HEV" exact="infection" post="•Acute, epidemic (genotype 1 or 2) hepatitis E •Acute"/>
 <result pre="settings of HEV infection •Acute, epidemic (genotype 1 or 2)" exact="hepatitis" post="E •Acute autochthonous (genotype 3 or 4-7) hepatitis E"/>
 <result pre="or 2) hepatitis E •Acute autochthonous (genotype 3 or 4-7)" exact="hepatitis" post="E •Acute hepatitis E superimposed on pre-existing chronic liver"/>
 <result pre="E •Acute autochthonous (genotype 3 or 4-7) hepatitis E •Acute" exact="hepatitis" post="E superimposed on pre-existing chronic liver disease (acute-on-chronic liver"/>
 <result pre="or 4-7) hepatitis E •Acute hepatitis E superimposed on pre-existing" exact="chronic" post="liver disease (acute-on-chronic liver disease) •Acute or chronic hepatitis"/>
 <result pre="4-7) hepatitis E •Acute hepatitis E superimposed on pre-existing chronic" exact="liver disease" post="(acute-on-chronic liver disease) •Acute or chronic hepatitis E in"/>
 <result pre="hepatitis E •Acute hepatitis E superimposed on pre-existing chronic liver" exact="disease" post="(acute-on-chronic liver disease) •Acute or chronic hepatitis E in"/>
 <result pre="superimposed on pre-existing chronic liver disease (acute-on-chronic liver disease) •Acute" exact="or chronic" post="hepatitis E in immunocompromised host (e.g., organ transplant recipients;"/>
 <result pre="on pre-existing chronic liver disease (acute-on-chronic liver disease) •Acute or" exact="chronic hepatitis" post="E in immunocompromised host (e.g., organ transplant recipients; chemotherapy"/>
 <result pre="pre-existing chronic liver disease (acute-on-chronic liver disease) •Acute or chronic" exact="hepatitis" post="E in immunocompromised host (e.g., organ transplant recipients; chemotherapy"/>
 <result pre="host (e.g., organ transplant recipients; chemotherapy administration; HIV positivity) •Chronic" exact="hepatitis" post="E Fig. 6.18 Hepatitis E. Hepatocytes are vacuolated and"/>
 <result pre="recipients; chemotherapy administration; HIV positivity) •Chronic hepatitis E Fig. 6.18" exact="Hepatitis" post="E. Hepatocytes are vacuolated and one to the left"/>
 <result pre="infiltrate, and macrophages contain brown ceroid pigment. Detection of HEV" exact="infection" post="in liver tissue can be accomplished by polymerase chain"/>
 <result pre="only licensed in China.73., 74., 75., 76. Differential diagnosis of" exact="acute" post="viral hepatitis The distinction of acute hepatitis from bile-duct"/>
 <result pre="licensed in China.73., 74., 75., 76. Differential diagnosis of acute" exact="viral hepatitis" post="The distinction of acute hepatitis from bile-duct obstruction rests"/>
 <result pre="in China.73., 74., 75., 76. Differential diagnosis of acute viral" exact="hepatitis" post="The distinction of acute hepatitis from bile-duct obstruction rests"/>
 <result pre="76. Differential diagnosis of acute viral hepatitis The distinction of" exact="acute hepatitis" post="from bile-duct obstruction rests mainly on the finding of"/>
 <result pre="Differential diagnosis of acute viral hepatitis The distinction of acute" exact="hepatitis" post="from bile-duct obstruction rests mainly on the finding of"/>
 <result pre="The portal tract oedema of duct obstruction is absent. Drug-related" exact="hepatitis" post="may be indistinguishable from viral hepatitis and should always"/>
 <result pre="duct obstruction is absent. Drug-related hepatitis may be indistinguishable from" exact="viral hepatitis" post="and should always be suspected if the cause of"/>
 <result pre="obstruction is absent. Drug-related hepatitis may be indistinguishable from viral" exact="hepatitis" post="and should always be suspected if the cause of"/>
 <result pre="and should always be suspected if the cause of the" exact="hepatitis" post="is in doubt. Features more common in drug-induced than"/>
 <result pre="is in doubt. Features more common in drug-induced than in" exact="viral hepatitis" post="include sharply defined perivenular necrosis, granulomas, bile-duct damage, abundant"/>
 <result pre="in doubt. Features more common in drug-induced than in viral" exact="hepatitis" post="include sharply defined perivenular necrosis, granulomas, bile-duct damage, abundant"/>
 <result pre="neutrophils or eosinophils and a poorly developed portal inflammatory reaction." exact="Cholestasis" post="may overshadow the hepatitic features. Autoimmune hepatitis may have"/>
 <result pre="developed portal inflammatory reaction. Cholestasis may overshadow the hepatitic features." exact="Autoimmune" post="hepatitis may have a clinically acute onset, histologically indistinguishable"/>
 <result pre="portal inflammatory reaction. Cholestasis may overshadow the hepatitic features. Autoimmune" exact="hepatitis" post="may have a clinically acute onset, histologically indistinguishable from"/>
 <result pre="overshadow the hepatitic features. Autoimmune hepatitis may have a clinically" exact="acute" post="onset, histologically indistinguishable from viral hepatitis or alternatively with"/>
 <result pre="hepatitis may have a clinically acute onset, histologically indistinguishable from" exact="viral hepatitis" post="or alternatively with histological features of chronic disease. This"/>
 <result pre="may have a clinically acute onset, histologically indistinguishable from viral" exact="hepatitis" post="or alternatively with histological features of chronic disease. This"/>
 <result pre="indistinguishable from viral hepatitis or alternatively with histological features of" exact="chronic" post="disease. This is discussed more fully in Chapter 9."/>
 <result pre="presence of pericellular fibrosis in affected areas. The differentiation of" exact="acute" post="from chronic hepatitis is briefly discussed under bridging necrosis"/>
 <result pre="pericellular fibrosis in affected areas. The differentiation of acute from" exact="chronic hepatitis" post="is briefly discussed under bridging necrosis in Chapter 4."/>
 <result pre="fibrosis in affected areas. The differentiation of acute from chronic" exact="hepatitis" post="is briefly discussed under bridging necrosis in Chapter 4."/>
 <result pre="necrosis in Chapter 4. While the parenchymal changes predominate in" exact="acute hepatitis," post="especially in perivenular areas, portal and periportal changes predominate"/>
 <result pre="especially in perivenular areas, portal and periportal changes predominate in" exact="chronic" post="disease. The distinction is sometimes difficult to make, especially"/>
 <result pre="The distinction is sometimes difficult to make, especially when extensive" exact="lobular" post="changes are found during an exacerbation of chronic hepatitis"/>
 <result pre="when extensive lobular changes are found during an exacerbation of" exact="chronic hepatitis" post="or in reactivated chronic hepatitis B, as described earlier."/>
 <result pre="extensive lobular changes are found during an exacerbation of chronic" exact="hepatitis" post="or in reactivated chronic hepatitis B, as described earlier."/>
 <result pre="found during an exacerbation of chronic hepatitis or in reactivated" exact="chronic hepatitis" post="B, as described earlier. Fate and morphological sequelae of"/>
 <result pre="during an exacerbation of chronic hepatitis or in reactivated chronic" exact="hepatitis" post="B, as described earlier. Fate and morphological sequelae of"/>
 <result pre="hepatitis B, as described earlier. Fate and morphological sequelae of" exact="acute" post="viral hepatitis Resolution As far as can be deduced"/>
 <result pre="B, as described earlier. Fate and morphological sequelae of acute" exact="viral hepatitis" post="Resolution As far as can be deduced from the"/>
 <result pre="as described earlier. Fate and morphological sequelae of acute viral" exact="hepatitis" post="Resolution As far as can be deduced from the"/>
 <result pre="can be deduced from the available evidence, most examples of" exact="hepatitis" post="A, B and E are followed by complete or"/>
 <result pre="examples of hepatitis A, B and E are followed by" exact="complete" post="or near-complete resolution and a return of the liver"/>
 <result pre="resolution and a return of the liver to normal. A" exact="chronic" post="course is probably more common when hepatitis B is"/>
 <result pre="to normal. A chronic course is probably more common when" exact="hepatitis" post="B is complicated by delta infection than otherwise, and"/>
 <result pre="probably more common when hepatitis B is complicated by delta" exact="infection" post="than otherwise, and in hepatitis C the risk of"/>
 <result pre="B is complicated by delta infection than otherwise, and in" exact="hepatitis" post="C the risk of chronicity is high. Even in"/>
 <result pre="the risk of chronicity is high. Even in patients whose" exact="hepatitis" post="resolves, some residual changes may persist for many months"/>
 <result pre="after clinical recovery (Fig. 6.19, Fig. 6.20 ). Fig. 6.19" exact="Acute" post="viral hepatitis: residual changes. Short septa extend from the"/>
 <result pre="clinical recovery (Fig. 6.19, Fig. 6.20 ). Fig. 6.19 Acute" exact="viral" post="hepatitis: residual changes. Short septa extend from the mildly"/>
 <result pre="are seen around the efferent venule below right. Fig. 6.20" exact="Acute" post="viral hepatitis: residual changes. Slender septa link portal tracts"/>
 <result pre="seen around the efferent venule below right. Fig. 6.20 Acute" exact="viral" post="hepatitis: residual changes. Slender septa link portal tracts (left"/>
 <result pre="are preserved. Scarring Localised collapse, scarring and regeneration following severe" exact="hepatitis" post="with bridging or panlobular necrosis sometimes produce a histological"/>
 <result pre="or need for liver transplantation Necrosis is usually severe. Regenerative" exact="hyperplasia" post="of surviving hepatocytes or progenitor cells may be seen."/>
 <result pre="hyperplasia of surviving hepatocytes or progenitor cells may be seen." exact="Chronic" post="hepatitis In regions where HBV vaccine programs have not"/>
 <result pre="of surviving hepatocytes or progenitor cells may be seen. Chronic" exact="hepatitis" post="In regions where HBV vaccine programs have not been"/>
 <result pre="vaccine programs have not been instituted, many individuals will develop" exact="chronic hepatitis" post="B. The availability of direct-acting antiviral agents to treat"/>
 <result pre="programs have not been instituted, many individuals will develop chronic" exact="hepatitis" post="B. The availability of direct-acting antiviral agents to treat"/>
 <result pre="hepatitis B. The availability of direct-acting antiviral agents to treat" exact="acute hepatitis" post="C virus infections is likely to dramatically reduce the"/>
 <result pre="B. The availability of direct-acting antiviral agents to treat acute" exact="hepatitis" post="C virus infections is likely to dramatically reduce the"/>
 <result pre="of direct-acting antiviral agents to treat acute hepatitis C virus" exact="infections" post="is likely to dramatically reduce the prevalence of chronic"/>
 <result pre="virus infections is likely to dramatically reduce the prevalence of" exact="chronic hepatitis" post="C in the future. Cirrhosis Cirrhosis resulting from infection"/>
 <result pre="infections is likely to dramatically reduce the prevalence of chronic" exact="hepatitis" post="C in the future. Cirrhosis Cirrhosis resulting from infection"/>
 <result pre="chronic hepatitis C in the future. Cirrhosis Cirrhosis resulting from" exact="infection" post="with a hepatitis virus almost always follows a period"/>
 <result pre="in the future. Cirrhosis Cirrhosis resulting from infection with a" exact="hepatitis" post="virus almost always follows a period of chronic hepatitis,"/>
 <result pre="with a hepatitis virus almost always follows a period of" exact="chronic hepatitis," post="with repeated or continuous hepatocellular necrosis and regeneration. Occasionally"/>
 <result pre="necrosis and regeneration. Occasionally it may follow directly after a" exact="single episode" post="of severe acute hepatitis where it is termed ‘postnecrotic"/>
 <result pre="it may follow directly after a single episode of severe" exact="acute hepatitis" post="where it is termed ‘postnecrotic cirrhosis’. Hepatocellular carcinoma This"/>
 <result pre="may follow directly after a single episode of severe acute" exact="hepatitis" post="where it is termed ‘postnecrotic cirrhosis’. Hepatocellular carcinoma This"/>
 <result pre="of severe acute hepatitis where it is termed ‘postnecrotic cirrhosis’." exact="Hepatocellular carcinoma" post="This may develop on the basis of cirrhosis in"/>
 <result pre="severe acute hepatitis where it is termed ‘postnecrotic cirrhosis’. Hepatocellular" exact="carcinoma" post="This may develop on the basis of cirrhosis in"/>
 <result pre="cirrhosis’. Hepatocellular carcinoma This may develop on the basis of" exact="cirrhosis" post="in patients infected with HBV or hepatitis C virus."/>
 <result pre="the basis of cirrhosis in patients infected with HBV or" exact="hepatitis" post="C virus. Occasionally, however, hepatocellular carcinoma is found in"/>
 <result pre="patients infected with HBV or hepatitis C virus. Occasionally, however," exact="hepatocellular carcinoma" post="is found in the absence of cirrhosis, usually after"/>
 <result pre="infected with HBV or hepatitis C virus. Occasionally, however, hepatocellular" exact="carcinoma" post="is found in the absence of cirrhosis, usually after"/>
 <result pre="C virus. Occasionally, however, hepatocellular carcinoma is found in the" exact="absence of" post="cirrhosis, usually after a prolonged period of chronic liver"/>
 <result pre="the absence of cirrhosis, usually after a prolonged period of" exact="chronic" post="liver disease76 (although the risk appears to be even"/>
 <result pre="non-cirrhotic patients with non-alcoholic steatohepatitis).77., 78. References References 1.Ben-AriZ.SamuelD.ZemelR.Fulminant non-A-G" exact="viral hepatitis" post="leading to liver transplantationArch Intern Med160200038839210668842 2.PetrovicL.M.ArkadopoulosN.DemetriouA.A.Activation of hepatic"/>
 <result pre="patients with non-alcoholic steatohepatitis).77., 78. References References 1.Ben-AriZ.SamuelD.ZemelR.Fulminant non-A-G viral" exact="hepatitis" post="leading to liver transplantationArch Intern Med160200038839210668842 2.PetrovicL.M.ArkadopoulosN.DemetriouA.A.Activation of hepatic"/>
 <result pre="hepatic stellate cells in liver tissue of patients with fulminant" exact="liver failure" post="after treatment with bioartificial liverHum Pathol3220011371137511774171 3.SchiødtF.V.DavernT.J.ShakilA.O.Viral hepatitis-related acute"/>
 <result pre="liver failure after treatment with bioartificial liverHum Pathol3220011371137511774171 3.SchiødtF.V.DavernT.J.ShakilA.O.Viral hepatitis-related" exact="acute" post="liver failureAm J Gastroenterol98200344845312591067 4.KirschR.YapJ.RobertsE.A.Clinicopathologic spectrum of massive and"/>
 <result pre="hepatic necrosis in infants and childrenHum Pathol40200951652619121848 5.PetersD.J.GreeneW.H.RuggieroF.Herpes simplex-induced fulminant" exact="hepatitis" post="in adults: a call for empiric therapyDig Dis Sci4520002399240411258565"/>
 <result pre="call for empiric therapyDig Dis Sci4520002399240411258565 6.PinnaA.D.RakelaJ.DemetrisA.J.Five cases of fulminant" exact="hepatitis" post="due to herpes simplex virus in adultsDig Dis Sci47200275075411991604"/>
 <result pre="therapyDig Dis Sci4520002399240411258565 6.PinnaA.D.RakelaJ.DemetrisA.J.Five cases of fulminant hepatitis due to" exact="herpes" post="simplex virus in adultsDig Dis Sci47200275075411991604 7.CollinL.MoulinP.JungersM.Epstein–Barr virus (EBV)-induced"/>
 <result pre="herpes simplex virus in adultsDig Dis Sci47200275075411991604 7.CollinL.MoulinP.JungersM.Epstein–Barr virus (EBV)-induced" exact="liver failure" post="in the absence of extensive liver-cell necrosis: a case"/>
 <result pre="adultsDig Dis Sci47200275075411991604 7.CollinL.MoulinP.JungersM.Epstein–Barr virus (EBV)-induced liver failure in the" exact="absence of" post="extensive liver-cell necrosis: a case for cytokine-induced liver dysfunction?J"/>
 <result pre="necrosis: a case for cytokine-induced liver dysfunction?J Hepatol41200417417515246231 8.WangW.H.WangH.L.Fulminant adenovirus" exact="hepatitis" post="following bone marrow transplantation. A case report and brief"/>
 <result pre="and brief review of the literatureArch Pathol Lab Med1272003e246e24812708923 9.LongerichT.HaferkampK.ToxU.Acute" exact="liver failure" post="in a renal transplant patient caused by adenoviral hepatitis"/>
 <result pre="liver failure in a renal transplant patient caused by adenoviral" exact="hepatitis" post="superimposed on a fibrosing cholestatic hepatitis BHum Pathol35200489489715257556 10.ChauT.N.LeeK.C.YaoH.SARS-associated"/>
 <result pre="patient caused by adenoviral hepatitis superimposed on a fibrosing cholestatic" exact="hepatitis" post="BHum Pathol35200489489715257556 10.ChauT.N.LeeK.C.YaoH.SARS-associated viral hepatitis caused by a novel"/>
 <result pre="hepatitis superimposed on a fibrosing cholestatic hepatitis BHum Pathol35200489489715257556 10.ChauT.N.LeeK.C.YaoH.SARS-associated" exact="viral hepatitis" post="caused by a novel coronavirus: report of three casesHepatology39200430231014767982"/>
 <result pre="superimposed on a fibrosing cholestatic hepatitis BHum Pathol35200489489715257556 10.ChauT.N.LeeK.C.YaoH.SARS-associated viral" exact="hepatitis" post="caused by a novel coronavirus: report of three casesHepatology39200430231014767982"/>
 <result pre="coronavirus: report of three casesHepatology39200430231014767982 11.NgW.-F.ToK.-F.LamW.W.L.The comparative pathology of severe" exact="acute" post="respiratory syndrome and avian influenza A subtype H5N1: a"/>
 <result pre="report of three casesHepatology39200430231014767982 11.NgW.-F.ToK.-F.LamW.W.L.The comparative pathology of severe acute" exact="respiratory" post="syndrome and avian influenza A subtype H5N1: a reviewHum"/>
 <result pre="of three casesHepatology39200430231014767982 11.NgW.-F.ToK.-F.LamW.W.L.The comparative pathology of severe acute respiratory" exact="syndrome" post="and avian influenza A subtype H5N1: a reviewHum Pathol37200638139016564911"/>
 <result pre="casesHepatology39200430231014767982 11.NgW.-F.ToK.-F.LamW.W.L.The comparative pathology of severe acute respiratory syndrome and" exact="avian influenza" post="A subtype H5N1: a reviewHum Pathol37200638139016564911 12.PolakosN.K.CornejoJ.C.MurrayD.A.Kupfer cell-dependent hepatitis"/>
 <result pre="avian influenza A subtype H5N1: a reviewHum Pathol37200638139016564911 12.PolakosN.K.CornejoJ.C.MurrayD.A.Kupfer cell-dependent" exact="hepatitis" post="occurs during influenza infectionAm J Pathol16820061169117816565492 13.AdamsD.H.HubscherS.G.Systemic viral infections"/>
 <result pre="12.PolakosN.K.CornejoJ.C.MurrayD.A.Kupfer cell-dependent hepatitis occurs during influenza infectionAm J Pathol16820061169117816565492 13.AdamsD.H.HubscherS.G.Systemic" exact="viral" post="infections and collateral damage in the liverAm J Pathol16820061057105916565481"/>
 <result pre="cell-dependent hepatitis occurs during influenza infectionAm J Pathol16820061169117816565492 13.AdamsD.H.HubscherS.G.Systemic viral" exact="infections" post="and collateral damage in the liverAm J Pathol16820061057105916565481 14.LauJ.Y.N.XieX.LaiM.M.C.Apoptosis"/>
 <result pre="and collateral damage in the liverAm J Pathol16820061057105916565481 14.LauJ.Y.N.XieX.LaiM.M.C.Apoptosis and" exact="viral" post="hepatitisSemin Liver Dis1819981691769606813 15.KlotzO.BeltT.H.The pathology of the liver in"/>
 <result pre="in northern Brazil: morphological, immunohistochemical and pathogenic aspects of Lábrea" exact="hepatitis" post="and yellow feverTrans Roy Soc Trop Med Hyg101200783183917568643 17.PhillipsM.J.BlendisL.M.PoucellS.Syncytial"/>
 <result pre="yellow feverTrans Roy Soc Trop Med Hyg101200783183917568643 17.PhillipsM.J.BlendisL.M.PoucellS.Syncytial giant-cell hepatitis." exact="Sporadic" post="hepatitis with distinctive pathological features, a severe clinical course"/>
 <result pre="feverTrans Roy Soc Trop Med Hyg101200783183917568643 17.PhillipsM.J.BlendisL.M.PoucellS.Syncytial giant-cell hepatitis. Sporadic" exact="hepatitis" post="with distinctive pathological features, a severe clinical course and"/>
 <result pre="featuresN Engl J Med32419914554601988831 18.FimmelC.J.GuoL.CompansR.W.A case of syncytial giant cell" exact="hepatitis" post="with features of a paramyxoviral infectionAm J Gastroenterol931998193119379772058 19.DevaneyK.GoodmanZ.D.IshakK.G.Postinfantile"/>
 <result pre="infectionAm J Gastroenterol931998193119379772058 19.DevaneyK.GoodmanZ.D.IshakK.G.Postinfantile giant-cell transformation in hepatitisHepatology1619923273331639341 20.LauJ.Y.N.KoukoulisG.Mieli-VerganiG.Syncytial giant-cell" exact="hepatitis" post="– a specific disease entity?J Hepatol1519922162191506641 21.ProtzerU.DienesH.P.BianchiL.Post-infantile giant cell"/>
 <result pre="giant-cell transformation in hepatitisHepatology1619923273331639341 20.LauJ.Y.N.KoukoulisG.Mieli-VerganiG.Syncytial giant-cell hepatitis – a specific" exact="disease" post="entity?J Hepatol1519922162191506641 21.ProtzerU.DienesH.P.BianchiL.Post-infantile giant cell hepatitis in patients with"/>
 <result pre="hepatitis – a specific disease entity?J Hepatol1519922162191506641 21.ProtzerU.DienesH.P.BianchiL.Post-infantile giant cell" exact="hepatitis" post="in patients with primary sclerosing cholangitis and autoimmune hepatitisLiver1619962742828878001"/>
 <result pre="disease entity?J Hepatol1519922162191506641 21.ProtzerU.DienesH.P.BianchiL.Post-infantile giant cell hepatitis in patients with" exact="primary sclerosing cholangitis" post="and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to autoimmune"/>
 <result pre="entity?J Hepatol1519922162191506641 21.ProtzerU.DienesH.P.BianchiL.Post-infantile giant cell hepatitis in patients with primary" exact="sclerosing cholangitis" post="and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to autoimmune"/>
 <result pre="Hepatol1519922162191506641 21.ProtzerU.DienesH.P.BianchiL.Post-infantile giant cell hepatitis in patients with primary sclerosing" exact="cholangitis" post="and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to autoimmune"/>
 <result pre="giant cell hepatitis in patients with primary sclerosing cholangitis and" exact="autoimmune" post="hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to autoimmune hepatitis type"/>
 <result pre="patients with primary sclerosing cholangitis and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell" exact="hepatitis" post="due to autoimmune hepatitis type II (LKM1+) presenting as"/>
 <result pre="sclerosing cholangitis and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to" exact="autoimmune" post="hepatitis type II (LKM1+) presenting as subfulminant hepatitisAm J"/>
 <result pre="cholangitis and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to autoimmune" exact="hepatitis" post="type II (LKM1+) presenting as subfulminant hepatitisAm J Gastroenterol95200079980110710079"/>
 <result pre="and autoimmune hepatitisLiver1619962742828878001 22.Ben-AriZ.BroidaE.MonseliseY.Syncytial giant-cell hepatitis due to autoimmune hepatitis" exact="type II" post="(LKM1+) presenting as subfulminant hepatitisAm J Gastroenterol95200079980110710079 23.MicchelliS.T.L.ThomasD.BoitnottJ.K.Hepatic giant"/>
 <result pre="presenting as subfulminant hepatitisAm J Gastroenterol95200079980110710079 23.MicchelliS.T.L.ThomasD.BoitnottJ.K.Hepatic giant cells in" exact="hepatitis" post="C virus (HCV) mono-infection and HCV/HIV co-infectionJ Clin Pathol6120081058106118682418"/>
 <result pre="mono-infection and HCV/HIV co-infectionJ Clin Pathol6120081058106118682418 24.SciotR.Van DammeB.DesmetV.J.Cholestatic features in" exact="hepatitis" post="AJ Hepatol319861721813025288 25.VolpesR.van den OordJ.J.DesmetV.J.Memory T cells represent the"/>
 <result pre="den OordJ.J.DesmetV.J.Memory T cells represent the predominant lymphocyte subset in" exact="acute" post="and chronic liver inflammationHepatology1319918268291674247 26.MietkiewskiJ.M.ScheuerP.J.Immunoglobulin-containing plasma cells in acute"/>
 <result pre="T cells represent the predominant lymphocyte subset in acute and" exact="chronic" post="liver inflammationHepatology1319918268291674247 26.MietkiewskiJ.M.ScheuerP.J.Immunoglobulin-containing plasma cells in acute hepatitisLiver5198584883889531 27.BardadinK.A.ScheuerP.J.Endothelial"/>
 <result pre="in acute and chronic liver inflammationHepatology1319918268291674247 26.MietkiewskiJ.M.ScheuerP.J.Immunoglobulin-containing plasma cells in" exact="acute" post="hepatitisLiver5198584883889531 27.BardadinK.A.ScheuerP.J.Endothelial cell changes in acute hepatitis. A light"/>
 <result pre="26.MietkiewskiJ.M.ScheuerP.J.Immunoglobulin-containing plasma cells in acute hepatitisLiver5198584883889531 27.BardadinK.A.ScheuerP.J.Endothelial cell changes in" exact="acute hepatitis." post="A light and electron microscopic studyJ Pathol14419842132206502298 28.ScheuerP.J.MaggiG.Hepatic fibrosis"/>
 <result pre="hepatocytesAm J Pathol14919964394488701983 32.RoskamsT.De VosR.van EykenP.Hepatic OV-6 expression in human" exact="liver disease" post="and rat experiments: evidence for hepatic progenitor cells in"/>
 <result pre="J Pathol14919964394488701983 32.RoskamsT.De VosR.van EykenP.Hepatic OV-6 expression in human liver" exact="disease" post="and rat experiments: evidence for hepatic progenitor cells in"/>
 <result pre="features, serology and outcome following transplantationJ Hepatol2319953633728655952 35.TeixeiraM.R.Jr.WellerI.V.D.MurrayA.M.The pathology of" exact="hepatitis" post="A in manLiver2198253607176838 36.AbeH.BeningerP.R.IkejiriN.Light microscopic findings of liver biopsy"/>
 <result pre="35.TeixeiraM.R.Jr.WellerI.V.D.MurrayA.M.The pathology of hepatitis A in manLiver2198253607176838 36.AbeH.BeningerP.R.IkejiriN.Light microscopic findings" exact="of liver" post="biopsy specimens from patients with hepatitis type A and"/>
 <result pre="36.AbeH.BeningerP.R.IkejiriN.Light microscopic findings of liver biopsy specimens from patients with" exact="hepatitis" post="type A and comparison with type BGastroenterology8219829389476174391 37.OkunoT.SanoA.DeguchiT.Pathology of"/>
 <result pre="microscopic findings of liver biopsy specimens from patients with hepatitis" exact="type A" post="and comparison with type BGastroenterology8219829389476174391 37.OkunoT.SanoA.DeguchiT.Pathology of acute hepatitis"/>
 <result pre="hepatitis type A and comparison with type BGastroenterology8219829389476174391 37.OkunoT.SanoA.DeguchiT.Pathology of" exact="acute hepatitis" post="A in humans. Comparison with acute hepatitis BAm J"/>
 <result pre="type A and comparison with type BGastroenterology8219829389476174391 37.OkunoT.SanoA.DeguchiT.Pathology of acute" exact="hepatitis" post="A in humans. Comparison with acute hepatitis BAm J"/>
 <result pre="BGastroenterology8219829389476174391 37.OkunoT.SanoA.DeguchiT.Pathology of acute hepatitis A in humans. Comparison with" exact="acute hepatitis" post="BAm J Clin Pathol8119841621696695857 38.PonzE.Garcia-PaganJ.C.BrugueraM.Hepatic fibrin-ring granulomas in a"/>
 <result pre="37.OkunoT.SanoA.DeguchiT.Pathology of acute hepatitis A in humans. Comparison with acute" exact="hepatitis" post="BAm J Clin Pathol8119841621696695857 38.PonzE.Garcia-PaganJ.C.BrugueraM.Hepatic fibrin-ring granulomas in a"/>
 <result pre="J Clin Pathol8119841621696695857 38.PonzE.Garcia-PaganJ.C.BrugueraM.Hepatic fibrin-ring granulomas in a patient with" exact="hepatitis" post="AGastroenterology10019912682701983832 39.RuelM.SevestreH.Henry-BiabaudE.Fibrin ring granulomas in hepatitis ADig Dis Sci371992191519171473440"/>
 <result pre="in a patient with hepatitis AGastroenterology10019912682701983832 39.RuelM.SevestreH.Henry-BiabaudE.Fibrin ring granulomas in" exact="hepatitis" post="ADig Dis Sci371992191519171473440 40.InoueK.YoshibaM.YotsuyanagiH.Chronic hepatitis A with persistent viral"/>
 <result pre="AGastroenterology10019912682701983832 39.RuelM.SevestreH.Henry-BiabaudE.Fibrin ring granulomas in hepatitis ADig Dis Sci371992191519171473440 40.InoueK.YoshibaM.YotsuyanagiH.Chronic" exact="hepatitis" post="A with persistent viral replicationJ Med Virol5019963223248950689 41.ChuC.W.HwangS.J.LuoJ.C.Comparison of"/>
 <result pre="in hepatitis ADig Dis Sci371992191519171473440 40.InoueK.YoshibaM.YotsuyanagiH.Chronic hepatitis A with persistent" exact="viral" post="replicationJ Med Virol5019963223248950689 41.ChuC.W.HwangS.J.LuoJ.C.Comparison of clinical, virologic and pathologic"/>
 <result pre="41.ChuC.W.HwangS.J.LuoJ.C.Comparison of clinical, virologic and pathologic features in patients with" exact="acute hepatitis" post="B and CJ Gastroenterol Hepatol16200120921411207903 42.UchidaT.ShimojimaS.GotohK.Pathology of livers infected"/>
 <result pre="of clinical, virologic and pathologic features in patients with acute" exact="hepatitis" post="B and CJ Gastroenterol Hepatol16200120921411207903 42.UchidaT.ShimojimaS.GotohK.Pathology of livers infected"/>
 <result pre="and CJ Gastroenterol Hepatol16200120921411207903 42.UchidaT.ShimojimaS.GotohK.Pathology of livers infected with ‘silent’" exact="hepatitis" post="B virus mutantLiver1419942512567997084 43.YukiN.NagaokaT.YamashiroM.Long-term histologic and virologic outcomes of"/>
 <result pre="hepatitis B virus mutantLiver1419942512567997084 43.YukiN.NagaokaT.YamashiroM.Long-term histologic and virologic outcomes of" exact="acute" post="self-limited hepatitis BHepatology3720031172117912717399 44.BamberM.MurrayA.ArborghB.A.Short incubation non-A, non-B hepatitis transmitted"/>
 <result pre="virus mutantLiver1419942512567997084 43.YukiN.NagaokaT.YamashiroM.Long-term histologic and virologic outcomes of acute self-limited" exact="hepatitis" post="BHepatology3720031172117912717399 44.BamberM.MurrayA.ArborghB.A.Short incubation non-A, non-B hepatitis transmitted by factor"/>
 <result pre="outcomes of acute self-limited hepatitis BHepatology3720031172117912717399 44.BamberM.MurrayA.ArborghB.A.Short incubation non-A, non-B" exact="hepatitis" post="transmitted by factor VIII concentrates in patients with congenital"/>
 <result pre="non-B hepatitis transmitted by factor VIII concentrates in patients with" exact="congenital" post="coagulation disordersGut2219818548596795093 45.KobayashiK.HashimotoE.LudwigJ.Liver biopsy features of acute hepatitis C"/>
 <result pre="in patients with congenital coagulation disordersGut2219818548596795093 45.KobayashiK.HashimotoE.LudwigJ.Liver biopsy features of" exact="acute hepatitis" post="C compared with hepatitis A, B and non-A, non-B,"/>
 <result pre="patients with congenital coagulation disordersGut2219818548596795093 45.KobayashiK.HashimotoE.LudwigJ.Liver biopsy features of acute" exact="hepatitis" post="C compared with hepatitis A, B and non-A, non-B,"/>
 <result pre="disordersGut2219818548596795093 45.KobayashiK.HashimotoE.LudwigJ.Liver biopsy features of acute hepatitis C compared with" exact="hepatitis" post="A, B and non-A, non-B, non-CLiver13199369738510489 46.ChuC.M.SheenI.S.LiawY.F.The role of"/>
 <result pre="hepatitis A, B and non-A, non-B, non-CLiver13199369738510489 46.ChuC.M.SheenI.S.LiawY.F.The role of" exact="hepatitis" post="C virus in fulminant viral hepatitis in an area"/>
 <result pre="non-B, non-CLiver13199369738510489 46.ChuC.M.SheenI.S.LiawY.F.The role of hepatitis C virus in fulminant" exact="viral hepatitis" post="in an area with endemic hepatitis A and BGastroenterology10719941891958020661"/>
 <result pre="non-CLiver13199369738510489 46.ChuC.M.SheenI.S.LiawY.F.The role of hepatitis C virus in fulminant viral" exact="hepatitis" post="in an area with endemic hepatitis A and BGastroenterology10719941891958020661"/>
 <result pre="virus in fulminant viral hepatitis in an area with endemic" exact="hepatitis" post="A and BGastroenterology10719941891958020661 47.GovindarajanS.De-CockK.M.RedekerA.G.Natural course of delta superinfection in"/>
 <result pre="hepatitis A and BGastroenterology10719941891958020661 47.GovindarajanS.De-CockK.M.RedekerA.G.Natural course of delta superinfection in" exact="chronic hepatitis" post="B virus-infected patients: histopathologic study with multiple liver biopsiesHepatology619866406443525368"/>
 <result pre="A and BGastroenterology10719941891958020661 47.GovindarajanS.De-CockK.M.RedekerA.G.Natural course of delta superinfection in chronic" exact="hepatitis" post="B virus-infected patients: histopathologic study with multiple liver biopsiesHepatology619866406443525368"/>
 <result pre="histopathologic study with multiple liver biopsiesHepatology619866406443525368 48.VermeG.AmorosoP.LettieriG.A histological study of" exact="hepatitis" post="delta virus liver diseaseHepatology61986130313073793008 49.LinH.-H.LiawY.-F.ChenT.-J.Natural course of patients with"/>
 <result pre="hepatitis delta virus liver diseaseHepatology61986130313073793008 49.LinH.-H.LiawY.-F.ChenT.-J.Natural course of patients with" exact="chronic" post="type B hepatitis following acute hepatitis delta virus superinfectionLiver919891291342747438"/>
 <result pre="delta virus liver diseaseHepatology61986130313073793008 49.LinH.-H.LiawY.-F.ChenT.-J.Natural course of patients with chronic" exact="type B" post="hepatitis following acute hepatitis delta virus superinfectionLiver919891291342747438 50.MorenoA.RamónY.CahalS.Sanded nuclei"/>
 <result pre="liver diseaseHepatology61986130313073793008 49.LinH.-H.LiawY.-F.ChenT.-J.Natural course of patients with chronic type B" exact="hepatitis" post="following acute hepatitis delta virus superinfectionLiver919891291342747438 50.MorenoA.RamónY.CahalS.Sanded nuclei in"/>
 <result pre="49.LinH.-H.LiawY.-F.ChenT.-J.Natural course of patients with chronic type B hepatitis following" exact="acute hepatitis" post="delta virus superinfectionLiver919891291342747438 50.MorenoA.RamónY.CahalS.Sanded nuclei in delta patientsLiver919893673712558268 51.SmedileA.FarciP.VermeG.Influence"/>
 <result pre="course of patients with chronic type B hepatitis following acute" exact="hepatitis" post="delta virus superinfectionLiver919891291342747438 50.MorenoA.RamónY.CahalS.Sanded nuclei in delta patientsLiver919893673712558268 51.SmedileA.FarciP.VermeG.Influence"/>
 <result pre="virus superinfectionLiver919891291342747438 50.MorenoA.RamónY.CahalS.Sanded nuclei in delta patientsLiver919893673712558268 51.SmedileA.FarciP.VermeG.Influence of delta" exact="infection" post="on severity of hepatitis BLancetii1982945947 52.PopperH.ThungS.N.GerberM.A.Histologic studies of severe"/>
 <result pre="in delta patientsLiver919893673712558268 51.SmedileA.FarciP.VermeG.Influence of delta infection on severity of" exact="hepatitis" post="BLancetii1982945947 52.PopperH.ThungS.N.GerberM.A.Histologic studies of severe delta agent infection in"/>
 <result pre="severity of hepatitis BLancetii1982945947 52.PopperH.ThungS.N.GerberM.A.Histologic studies of severe delta agent" exact="infection" post="in Venezuelan IndiansHepatology319839069126629319 53.BuitragoB.PopperH.HadlerS.C.Specific histologic features of Santa Marta"/>
 <result pre="histologic features of Santa Marta hepatitis: a severe form of" exact="hepatitis" post="delta-virus infection in Northern South AmericaHepatology61986128512913793005 54.LefkowitchJ.H.GoldsteinH.YattoR.Cytopathic liver injury"/>
 <result pre="of Santa Marta hepatitis: a severe form of hepatitis delta-virus" exact="infection" post="in Northern South AmericaHepatology61986128512913793005 54.LefkowitchJ.H.GoldsteinH.YattoR.Cytopathic liver injury in acute"/>
 <result pre="delta-virus infection in Northern South AmericaHepatology61986128512913793005 54.LefkowitchJ.H.GoldsteinH.YattoR.Cytopathic liver injury in" exact="acute" post="delta virus hepatitisGastroenterology921987126212663557018 55.RizzettoM.Hepatitis D: thirty years afterJ Hepatol5020091043105019285743"/>
 <result pre="virus hepatitisGastroenterology921987126212663557018 55.RizzettoM.Hepatitis D: thirty years afterJ Hepatol5020091043105019285743 56.DaviesS.E.LauJ.Y.N.O’GradyJ.G.Evidence that" exact="hepatitis" post="D virus needs hepatitis B virus to cause hepatocellular"/>
 <result pre="thirty years afterJ Hepatol5020091043105019285743 56.DaviesS.E.LauJ.Y.N.O’GradyJ.G.Evidence that hepatitis D virus needs" exact="hepatitis" post="B virus to cause hepatocellular damageAm J Clin Pathol9819925545581462952"/>
 <result pre="E: an emerging awareness of an old diseaseJ Hepatol48200849450318192058 WooP.C.Y.LauS.K.P.TengJ.L.L.New" exact="hepatitis" post="E virus genotype in camels, the Middle EastEmerg Inf"/>
 <result pre="EastEmerg Inf Dis20201410441048 Kenney SP. The current host range of" exact="hepatitis" post="E viruses. Viruses. 2019;11(5):452.https://doi:10.3390/v11050452. ReinD.B.StevensG.A.TheakerJ.The global burden of hepatitis"/>
 <result pre="of hepatitis E viruses. Viruses. 2019;11(5):452.https://doi:10.3390/v11050452. ReinD.B.StevensG.A.TheakerJ.The global burden of" exact="hepatitis" post="E virus genotypes 1 and 2 in 2005Hepatology55201298899722121109 HakimM.WangW.BramerW.M.The"/>
 <result pre="genotypes 1 and 2 in 2005Hepatology55201298899722121109 HakimM.WangW.BramerW.M.The global burden of" exact="hepatitis" post="E outbreaks: a systematic reviewLiver Int3720171931 60.MalcolmP.DaltonH.HussainiH.S.The histology of"/>
 <result pre="hepatitis E outbreaks: a systematic reviewLiver Int3720171931 60.MalcolmP.DaltonH.HussainiH.S.The histology of" exact="acute" post="autochthonous hepatitis E virus infectionHistopathology51200719019417650215 ChenE.Y.BaumK.CollinsW.Hepatitis E masquerading as"/>
 <result pre="outbreaks: a systematic reviewLiver Int3720171931 60.MalcolmP.DaltonH.HussainiH.S.The histology of acute autochthonous" exact="hepatitis" post="E virus infectionHistopathology51200719019417650215 ChenE.Y.BaumK.CollinsW.Hepatitis E masquerading as drug-induced liver"/>
 <result pre="virus infectionHistopathology51200719019417650215 ChenE.Y.BaumK.CollinsW.Hepatitis E masquerading as drug-induced liver injuryHepatology5620122420242323175167 DavernT.J.ChalasaniN.FontanaR.J.Acute" exact="hepatitis" post="E infection accounts for some cases of suspected drug-induced"/>
 <result pre="ChenE.Y.BaumK.CollinsW.Hepatitis E masquerading as drug-induced liver injuryHepatology5620122420242323175167 DavernT.J.ChalasaniN.FontanaR.J.Acute hepatitis E" exact="infection" post="accounts for some cases of suspected drug-induced liver injuryGastroenterology14120111665167221855518"/>
 <result pre="for some cases of suspected drug-induced liver injuryGastroenterology14120111665167221855518 MemonA.MirandaJ.Hepatitis E" exact="virus infection" post="in a patient with suspected drug-induced liver injuryBMJ Case"/>
 <result pre="some cases of suspected drug-induced liver injuryGastroenterology14120111665167221855518 MemonA.MirandaJ.Hepatitis E virus" exact="infection" post="in a patient with suspected drug-induced liver injuryBMJ Case"/>
 <result pre="Clin N Am462017393408 HamidS.S.AtiqM.ShehzadF.Hepatitis E virus superinfection in patients with" exact="chronic" post="liver diseaseHepatology36200247447812143058 LeeG.-H.TanB.-H.Chi-YuanE.Chronic infection with camelid hepatitis E virus"/>
 <result pre="E virus superinfection in patients with chronic liver diseaseHepatology36200247447812143058 LeeG.-H.TanB.-H.Chi-YuanE.Chronic" exact="infection" post="with camelid hepatitis E virus in a liver transplant"/>
 <result pre="in patients with chronic liver diseaseHepatology36200247447812143058 LeeG.-H.TanB.-H.Chi-YuanE.Chronic infection with camelid" exact="hepatitis" post="E virus in a liver transplant recipient who regularly"/>
 <result pre="Lenggenhager D, Weber A. Clinicopathologic features and pathologic diagnosis of" exact="hepatitis" post="E. Hum Pathol. https://doi:10.1016/j.humpath.2019.10.003. 64.RamachandranJ.EapenC.E.KangG.Hepatitis E superinfection produces severe"/>
 <result pre="https://doi:10.1016/j.humpath.2019.10.003. 64.RamachandranJ.EapenC.E.KangG.Hepatitis E superinfection produces severe decompensation in patients with" exact="chronic" post="liver diseaseJ Gastroenterol Hepatol19200413413814731121 65.KamarN.SelvesJ.MansuyJ.-M.Hepatitis E virus and chronic"/>
 <result pre="with chronic liver diseaseJ Gastroenterol Hepatol19200413413814731121 65.KamarN.SelvesJ.MansuyJ.-M.Hepatitis E virus and" exact="chronic hepatitis" post="in organ-transplant recipientsN Engl J Med358200881181718287603 66.KamarN.MansuyJ.-M.CointaultO.Hepatitis E virus-related"/>
 <result pre="chronic liver diseaseJ Gastroenterol Hepatol19200413413814731121 65.KamarN.SelvesJ.MansuyJ.-M.Hepatitis E virus and chronic" exact="hepatitis" post="in organ-transplant recipientsN Engl J Med358200881181718287603 66.KamarN.MansuyJ.-M.CointaultO.Hepatitis E virus-related"/>
 <result pre="hepatitis in organ-transplant recipientsN Engl J Med358200881181718287603 66.KamarN.MansuyJ.-M.CointaultO.Hepatitis E virus-related" exact="cirrhosis" post="in kidney- and kidney–pancreas-transplant recipientsAm J Transplant820081744174818557740 67.AggarwalR.Hepatitis E:"/>
 <result pre="and kidney–pancreas-transplant recipientsAm J Transplant820081744174818557740 67.AggarwalR.Hepatitis E: does it cause" exact="chronic" post="hepatitis?Hepatology4820081328133018821611 68.DienesH.P.HütterothT.BianchiL.Hepatitis A-like non-A, non-B hepatitis: light and electron"/>
 <result pre="69.AsherL.V.S.InnisB.L.ShresthaM.P.Virus-like particles in the liver of a patient with fulminant" exact="hepatitis" post="and antibody to hepatitis E virusJ Med Virol3119902292332391510 70.BeerA.HolzmannH.PischkeS.Chronic"/>
 <result pre="liver of a patient with fulminant hepatitis and antibody to" exact="hepatitis" post="E virusJ Med Virol3119902292332391510 70.BeerA.HolzmannH.PischkeS.Chronic hepatitis E is associated"/>
 <result pre="hepatitis and antibody to hepatitis E virusJ Med Virol3119902292332391510 70.BeerA.HolzmannH.PischkeS.Chronic" exact="hepatitis" post="E is associated with cholangitisLiver Int3920191876188331102493 71.LenggenhagerD.GouttenoireJ.MalehmirM.Visualization of hepatitis"/>
 <result pre="70.BeerA.HolzmannH.PischkeS.Chronic hepatitis E is associated with cholangitisLiver Int3920191876188331102493 71.LenggenhagerD.GouttenoireJ.MalehmirM.Visualization of" exact="hepatitis" post="E virus RNA and proteins in the human liverJ"/>
 <result pre="RNA and proteins in the human liverJ Hepatol67201747147928412294 72.ProstS.CrossanC.L.DaltonH.R.Detection of" exact="viral hepatitis" post="E in clinical liver biopsiesHistopathology71201758059028543644 73.Innis BL, Lynch JA."/>
 <result pre="and proteins in the human liverJ Hepatol67201747147928412294 72.ProstS.CrossanC.L.DaltonH.R.Detection of viral" exact="hepatitis" post="E in clinical liver biopsiesHistopathology71201758059028543644 73.Innis BL, Lynch JA."/>
 <result pre="in clinical liver biopsiesHistopathology71201758059028543644 73.Innis BL, Lynch JA. Immunization against" exact="hepatitis" post="E. Cold Spring Harb Perspect Med 2018;8(11). https://doi:10.1101/cshperspect.a032573. 74.LiY.HuangX.ZhangZ.Prophylactic"/>
 <result pre="hepatitis E. Cold Spring Harb Perspect Med 2018;8(11). https://doi:10.1101/cshperspect.a032573. 74.LiY.HuangX.ZhangZ.Prophylactic" exact="hepatitis" post="E vaccines: antigenic analysis and serological evaluationViruses12202010910.3390/v12010109 75.MelgaçoJ.G.GardinalliN.R.Motta de"/>
 <result pre="MelloLealM.Lewis-XimenezL.L.PintoM.A.Hepatitis E: update on prevention and controlBiomed Res Int2018576920129546064 76.DesaiA.SandhuS.LaiJ.-P.SandhuD.S.Hepatocellular" exact="carcinoma" post="in non-cirrhotic liver: a comprehensive reviewWorld J Hepatol11201911830705715 77.BoyleM.AnsteeQ.M.Editorial:"/>
 <result pre="carcinoma in non-cirrhotic liver: a comprehensive reviewWorld J Hepatol11201911830705715 77.BoyleM.AnsteeQ.M.Editorial:" exact="hepatocellular carcinoma" post="in non-cirrhotic NASH—a troubling realityAliment Pharmacol Ther4820181021102330318679 78.StineJ.G.WentworthB.J.ZimmetA.Systemic review"/>
 <result pre="in non-cirrhotic liver: a comprehensive reviewWorld J Hepatol11201911830705715 77.BoyleM.AnsteeQ.M.Editorial: hepatocellular" exact="carcinoma" post="in non-cirrhotic NASH—a troubling realityAliment Pharmacol Ther4820181021102330318679 78.StineJ.G.WentworthB.J.ZimmetA.Systemic review"/>
 <result pre="troubling realityAliment Pharmacol Ther4820181021102330318679 78.StineJ.G.WentworthB.J.ZimmetA.Systemic review with meta-analysis: risk of" exact="hepatocellular carcinoma" post="in non-alcoholic steatohepatitis without cirrhosis compared to other liver"/>
 <result pre="realityAliment Pharmacol Ther4820181021102330318679 78.StineJ.G.WentworthB.J.ZimmetA.Systemic review with meta-analysis: risk of hepatocellular" exact="carcinoma" post="in non-alcoholic steatohepatitis without cirrhosis compared to other liver"/>
 <result pre="with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without" exact="cirrhosis" post="compared to other liver diseasesAliment Pharmacol Ther48201869670330136293 References General"/>
 <result pre="without cirrhosis compared to other liver diseasesAliment Pharmacol Ther48201869670330136293 References" exact="General" post="reading KimB.Y.KimW.R.Epidemiology of hepatitis B virus infection in the"/>
 <result pre="other liver diseasesAliment Pharmacol Ther48201869670330136293 References General reading KimB.Y.KimW.R.Epidemiology of" exact="hepatitis" post="B virus infection in the United StatesClin Liver Dis12201813"/>
 <result pre="diseasesAliment Pharmacol Ther48201869670330136293 References General reading KimB.Y.KimW.R.Epidemiology of hepatitis B" exact="virus infection" post="in the United StatesClin Liver Dis12201813 LenggenhagerD.WeberA.Hepatitis E virus"/>
 <result pre="Pharmacol Ther48201869670330136293 References General reading KimB.Y.KimW.R.Epidemiology of hepatitis B virus" exact="infection" post="in the United StatesClin Liver Dis12201813 LenggenhagerD.WeberA.Hepatitis E virus"/>
 <result pre="and liver pathologyGastroenterol Clin N Am462017393408 MorozovV.A.LagayeS.Hepatitis C virus: morphogenesis," exact="infection" post="and therapyWorld J Hepatol10201818621229527256 NimgaonkarI.DingQ,.SchwartzR.E.PlossA.Hepatitis E virus: advances and"/>
 <result pre="E virus: advances and challengesNat Rev Gastroenterol Hepatol1520189611029162935 SchmidR.History of" exact="viral" post="hepatitis: a tale of dogmas and misinterpretationsJ Gastroenterol Hepatol16200171872211446877"/>
</results>
